Trulieve Could Benefit From Uplisting To Major Index
Trulieve Cannabis Corp. is exploring the possibility of uplisting its stock to a major US index. The company is expected to benefit from the recent rescheduling of medical cannabis, which could enhance its market position. Despite a positive outlook, the author maintains a Hold rating on the stock for now.
- ▪Trulieve is considering uplisting its stock to a major US index.
- ▪The company reported in-line Q1-2026 financial performance.
- ▪Trulieve's stock price has increased by 56% over the past year.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Earnings Analysis","item":"https://seekingalpha.com/earnings/earnings-analysis"},{"@type":"ListItem","position":3,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4905899-trulieve-stock-could-benefit-from-uplisting-to-major-index"},"author":{"@type":"Person","name":"Alan…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
